NANOVIRICIDES, INC. Payments of Financing Costs
NANOVIRICIDES, INC. (NNVC) reported Payments of Financing Costs of $0 for the 6-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2023-05-15
- NANOVIRICIDES, INC. payments of financing costs for the quarter ending 2022-03-31 was $0.00.
- NANOVIRICIDES, INC. payments of financing costs for the quarter ending 2021-12-31 was $37.41K.
- NANOVIRICIDES, INC. payments of financing costs for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- NANOVIRICIDES, INC. payments of financing costs for the quarter ending 2021-03-31 was $0.00.
- NANOVIRICIDES, INC. payments of financing costs for fiscal 2020 was $12.19K.
- NANOVIRICIDES, INC. payments of financing costs for fiscal 2019 was $0.00.
- NANOVIRICIDES, INC. payments of financing costs for fiscal 2018 was $0.00.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-Q · filed 2023-02-14 | |||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $37.41K derived: sum of 2 quarters · filed 2023-05-15 | $37.41K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $37.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $37.41K 10-Q · filed 2023-02-14 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$41.02K derived: sum of 2 quarters · filed 2022-05-16 | $0.00 10-Q · filed 2022-05-16 | |
| 2020-12-31 | -$41.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $0.00 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | $41.02K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $12.19K 10-K · filed 2021-10-12 | |||
| 2019-12-31 | $141.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $383.18K 10-Q · filed 2020-02-14 | ||
| 2019-09-30 | $242.10K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $0.00 10-K · filed 2021-10-12 | |||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-14 | |||
| 2018-06-30 | $0.00 10-K · filed 2020-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |